Global Human Cytomegalovirus Envelope Glycoprotein B Market Overview
Human Cytomegalovirus (HCMV) Envelope Glycoprotein B (gB) is a highly conserved viral surface protein essential for viral entry, cell fusion, and immune recognition. It is one of the most intensively studied antigens for CMV vaccine development and immunotherapeutic applications, given its strong ability to induce neutralizing antibody and T-cell responses.
HCMV infection poses serious risks to immunocompromised patients, transplant recipients, pregnant women, and neonates, making gB-based vaccines and biologics a strategic priority in infectious disease prevention. Market activity is currently concentrated in clinical-stage vaccines, monoclonal antibody programs, and recombinant protein platforms, with limited commercial availability but strong long-term growth potential.
The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at XX million USD in 2020 and is projected to reach XX million USD by 2036, expanding at a CAGR of XX% during 2026–2036, driven primarily by vaccine pipeline progress and increasing congenital CMV awareness.
Key Market Players
The market is highly R&D-driven, with participation from pharmaceutical companies, vaccine developers, and biotechnology firms:
-
Astellas Pharma
-
VBI Vaccines
-
Trellis Bioscience
-
Vakzine Projekt Management
-
Vical
-
Merck
-
Pfizer
-
GSK
-
Sanofi
-
Moderna
Large pharmaceutical companies are increasingly partnering with biotech firms to accelerate gB-based CMV vaccine and antibody programs.
Market Segmentation Analysis
By Product Type
-
CSJ-148 (monoclonal antibody targeting CMV gB)
-
CyMVectin (recombinant gB vaccine candidate)
-
TRL-345 (antibody-based therapy)
-
PPCM (Passive Polyclonal CMV Products)
-
Recombinant gB Vaccines
-
mRNA-based gB Candidates
-
Other Pipeline Products
By Technology Platform
-
Recombinant Protein Vaccines
-
Viral Vector-based Vaccines
-
DNA Vaccines
-
mRNA Vaccines
-
Monoclonal Antibodies
By Application
-
Infectious Disease Prevention
-
Transplant Medicine
-
Oncology Support (Immunocompromised Patients)
-
Women’s & Maternal Health
-
Congenital CMV Prevention
-
Other Clinical Uses
By End User
-
Hospitals & Transplant Centers
-
Research Institutes
-
Specialty Clinics
-
Vaccine Procurement Agencies
Regional Analysis
North America
-
Largest R&D and clinical trial hub
-
Strong NIH and private funding
-
High awareness of congenital CMV
Europe
-
Active vaccine research ecosystem
-
Strong regulatory support for orphan and preventive vaccines
-
Notable clinical activity in Germany, UK, and France
Asia-Pacific
-
Emerging market for CMV vaccine trials
-
Increasing transplant procedures in China, Japan, and India
-
Growing government investment in vaccine self-reliance
Central & South America
-
Limited commercial presence
-
Potential long-term growth via public immunization programs
Middle East & Africa
-
Early-stage market
-
Demand concentrated in tertiary hospitals and transplant centers
Porter’s Five Forces Analysis
Threat of New Entrants – Low
High R&D costs, long clinical timelines, and regulatory hurdles restrict entry.
Bargaining Power of Suppliers – Moderate
Specialized biologics manufacturing and antigen production create some supplier leverage.
Bargaining Power of Buyers – Low
Limited product availability and unmet clinical need reduce buyer power.
Threat of Substitutes – Low
No approved CMV vaccine alternatives currently exist.
Competitive Rivalry – Moderate
Competition is pipeline-driven rather than price-driven.
SWOT Analysis
Strengths
-
High unmet medical need
-
Strong immunogenicity of gB antigen
-
Growing global awareness of congenital CMV
Weaknesses
-
Long development timelines
-
High clinical trial failure risk
-
Limited near-term revenue
Opportunities
-
First-to-market CMV vaccine potential
-
Expansion into maternal immunization
-
Partnerships with global vaccine alliances
Threats
-
Clinical trial setbacks
-
Regulatory delays
-
Competition from non-gB CMV targets
Market Trends
-
Shift toward multivalent CMV vaccines
-
Integration of mRNA and novel adjuvants
-
Increased focus on maternal and neonatal protection
-
Strategic pharma-biotech collaborations
-
Government-backed funding for CMV prevention
Market Drivers and Challenges
Key Drivers
-
High prevalence of congenital CMV
-
Increasing transplant procedures worldwide
-
Advances in vaccine platforms
Key Challenges
-
Complex immune evasion mechanisms of CMV
-
Lengthy and costly clinical trials
-
Limited short-term commercial returns
Value Chain Analysis
-
Antigen Discovery & Design
-
Recombinant Protein / Nucleic Acid Production
-
Preclinical & Clinical Development
-
Regulatory Approval
-
Manufacturing & Scale-up
-
Distribution to Hospitals & Immunization Programs
Quick Recommendations for Stakeholders
-
Biotech Companies: Focus on differentiated platforms and combination antigen strategies.
-
Pharmaceutical Firms: Partner early with CMV-focused innovators to reduce risk.
-
Investors: Take a long-term view aligned with vaccine pipeline milestones.
-
Healthcare Systems: Increase congenital CMV screening and awareness programs.
-
Policy Makers: Support CMV vaccine development through grants and fast-track pathways.
Table of Contents
Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Report 2018
1 Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.1 Product Overview and Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Classification of Human Cytomegalovirus Envelope Glycoprotein B by Product Category
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Sales) Comparison by Type
1.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 CSJ-148
1.2.4 CyMVectin
1.2.5 TRL-345
1.2.6 PPCM
1.2.7 Cytomegalovirus Vaccine
1.2.8 Others
1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market by Application/End Users
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales (Volume) and Market Share Comparison by Application
1.3.1 Infectious Disease
1.3.2 Oncology
1.3.3 Women's Health
1.3.4 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market by Region
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Value) Comparison by Region
1.4.2 United States Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.4.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.4.4 China Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.4.5 Japan Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.4.6 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.4.7 India Human Cytomegalovirus Envelope Glycoprotein B Status and Prospect
1.5 Global Market Size (Value and Volume) of Human Cytomegalovirus Envelope Glycoprotein B
1.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate
1.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate
2 Global Human Cytomegalovirus Envelope Glycoprotein B Competition by Players/Suppliers, Type and Application
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Competition by Players/Suppliers
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Share by Players/Suppliers ()
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B (Volume and Value) by Type
2.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Type ()
2.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type ()
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B (Volume and Value) by Region
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales and Market Share by Region ()
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Region ()
2.4 Global Human Cytomegalovirus Envelope Glycoprotein B (Volume) by Application
3 United States Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
3.1 United States Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
3.1.1 United States Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
3.1.2 United States Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
3.1.3 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
3.2 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
3.3 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
3.4 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
4 Europe Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
4.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
4.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
4.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
4.1.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
4.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
4.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
4.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
5 China Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
5.1 China Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
5.1.1 China Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
5.1.2 China Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
5.1.3 China Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
5.2 China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
5.3 China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
5.4 China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
6 Japan Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
6.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
6.1.1 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
6.1.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
6.1.3 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
6.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
6.3 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
6.4 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
7.1 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
7.1.1 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
7.1.2 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
7.1.3 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
7.2 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
7.3 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
7.4 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
8 India Human Cytomegalovirus Envelope Glycoprotein B (Volume, Value and Sales Price)
8.1 India Human Cytomegalovirus Envelope Glycoprotein B Sales and Value ()
8.1.1 India Human Cytomegalovirus Envelope Glycoprotein B Sales and Growth Rate ()
8.1.2 India Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate ()
8.1.3 India Human Cytomegalovirus Envelope Glycoprotein B Sales Price Trend ()
8.2 India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Players ()
8.3 India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Type ()
8.4 India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Market Share by Application ()
9 Global Human Cytomegalovirus Envelope Glycoprotein B Players/Suppliers Profiles and Sales Data
9.1 Astellas Pharma Inc.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Human Cytomegalovirus Envelope Glycoprotein B Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Trellis Bioscience, Inc.
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Human Cytomegalovirus Envelope Glycoprotein B Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 Vakzine Projekt Management GmbH
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Human Cytomegalovirus Envelope Glycoprotein B Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
9.4 VBI Vaccine Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Human Cytomegalovirus Envelope Glycoprotein B Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin ()
9.4.4 Main Business/Business Overview
9.5 Vical Incorporated
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Human Cytomegalovirus Envelope Glycoprotein B Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin ()
9.5.4 Main Business/Business Overview
...
10 Human Cytomegalovirus Envelope Glycoprotein B Maufacturing Cost Analysis
10.1 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Human Cytomegalovirus Envelope Glycoprotein B Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast (2018-2025)
14.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price and Trend Forecast (2018-2025)
14.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2018-2025)
14.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2018-2025)
14.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price Forecast by Type (2018-2025)
14.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Comparison (K Pcs) by Type
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type (Product Category) in
Figure CSJ-148 Product Picture
Figure CyMVectin Product Picture
Figure TRL-345 Product Picture
Figure PPCM Product Picture
Figure Cytomegalovirus Vaccine Product Picture
Figure Others Product Picture
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Comparison (K Pcs) by Application
Figure Global Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application in
Figure Infectious Disease Examples
Table Key Downstream Customer in Infectious Disease
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Women's Health Examples
Table Key Downstream Customer in Women's Health
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (Million USD) by Regions
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure China Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure India Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) and Growth Rate
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) of Key Players/Suppliers ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players/Suppliers ()
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players/Suppliers
Figure Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Players/Suppliers
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Players/Suppliers ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) by Players/Suppliers ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players/Suppliers ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Players
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Market Share by Type ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share (K Pcs) by Type ()
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Type ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Market Share by Type ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type ()
Figure Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate by Type ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) and Market Share by Region ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Region ()
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Region ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate by Region in
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Market Share by Region ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share (%) by Region ()
Figure Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Region ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate by Region in
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Market Share by Region ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share (%) by Region ()
Figure Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Region ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region in
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) and Market Share by Application ()
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Share (%) by Application ()
Figure Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application ()
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure United States Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Figure China Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure China Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure China Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure China Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Figure India Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) and Growth Rate ()
Figure India Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate ()
Figure India Human Cytomegalovirus Envelope Glycoprotein B Sales Price (USD/Pcs) Trend ()
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Players ()
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players ()
Figure India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Players in
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Type ()
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type ()
Figure India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Type in
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) by Application ()
Table India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application ()
Figure India Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Market Share by Application in
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate ()
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Global Market Share ()
Figure Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Global Market Share ()
Table Trellis Bioscience, Inc. Basic Information List
Table Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate ()
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales Global Market Share ()
Figure Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Revenue Global Market Share ()
Table Vakzine Projekt Management GmbH Basic Information List
Table Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate ()
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales Global Market Share (
Figure Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Revenue Global Market Share ()
Table VBI Vaccine Inc Basic Information List
Table VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate ()
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales Global Market Share ()
Figure VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Revenue Global Market Share ()
Table Vical Incorporated Basic Information List
Table Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate ()
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales Global Market Share ()
Figure Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Revenue Global Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain Analysis
Table Raw Materials Sources of Human Cytomegalovirus Envelope Glycoprotein B Major Players in
Table Major Buyers of Human Cytomegalovirus Envelope Glycoprotein B
Table Distributors/Traders List
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global
Key Market Players
The market is highly R&D-driven, with participation from pharmaceutical companies, vaccine developers, and biotechnology firms:
-
Astellas Pharma
-
VBI Vaccines
-
Trellis Bioscience
-
Vakzine Projekt Management
-
Vical
-
Merck
-
Pfizer
-
GSK
-
Sanofi
-
Moderna
Large pharmaceutical companies are increasingly partnering with biotech firms to accelerate gB-based CMV vaccine and antibody programs.
Market Segmentation Analysis
By Product Type
-
CSJ-148 (monoclonal antibody targeting CMV gB)
-
CyMVectin (recombinant gB vaccine candidate)
-
TRL-345 (antibody-based therapy)
-
PPCM (Passive Polyclonal CMV Products)
-
Recombinant gB Vaccines
-
mRNA-based gB Candidates
-
Other Pipeline Products
By Technology Platform
-
Recombinant Protein Vaccines
-
Viral Vector-based Vaccines
-
DNA Vaccines
-
mRNA Vaccines
-
Monoclonal Antibodies
By Application
-
Infectious Disease Prevention
-
Transplant Medicine
-
Oncology Support (Immunocompromised Patients)
-
Women’s & Maternal Health
-
Congenital CMV Prevention
-
Other Clinical Uses
By End User
-
Hospitals & Transplant Centers
-
Research Institutes
-
Specialty Clinics
-
Vaccine Procurement Agencies
